Selank
Men's HealthMen's-health clinics treat Selank as one component in a layered hormonal optimisation framework. A Russian-developed heptapeptide derived from tuftsin — anxiolytic without sedation, supported by clinical trial data in generalised anxiety disorder. The relevant questions for male users are: does it interact with the HPG axis, is it compatible with current TRT or HCG protocols, and what are its effects on prostate, hematocrit, and cardiovascular indices over a CNS effect lasts hours; plasma short-pharmacokinetics Selank cycle? The sections below address each.
Key Takeaways
Male-physiology lens: Selank is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations. Mechanism: Modulates GABA-A receptor systems indirectly. Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel. Male dose: 300 mcg per spray; 2-3 sprays daily daily for 2-4 week courses via intranasal/subq; cycle 8-12 weeks. Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.
Male users' practical questions about Selank reduce to: hormonal coherence, TRT integration, and prostate / cardiovascular safety. Modulates GABA-A receptor systems indirectly. Increases serotonin metabolism via enkephalinase inhibition. Influences IL-6, BDNF, and TNF-α. The result is anxiolysis without the sedation, dependence, or motor impairment of benzodiazepines. The mechanism shapes the answer to each. The subsections below work through HPG-axis impact and TRT compatibility before examining the body composition and male-physiology response.
Compatibility with TRT and post-cycle protocols
For men currently on TRT or planning a post-cycle restart, Selank is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.
Sexual function and prostate considerations
Where Selank alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.
Male body composition and performance response
Male users typically respond to Selank on the recovery, lean-mass, or visceral-fat dimension depending on the compound's primary pharmacology. Modulates GABA-A receptor systems indirectly. Increases serotonin metabolism via enkephalinase inhibition. Influences IL-6, BDNF, and TNF-α. The result is anxiolysis without the sedation, dependence, or motor impairment of benzodiazepines. For men whose body composition goals are driven by training, the dose-timing relative to workouts and sleep is often the critical lever rather than the absolute dose itself.
For hpg axis support in male users, Selank is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.
Strength & Power in men responds to Selank with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.
Where male users target erectile function, Selank is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.
For testosterone optimisation in male users, Selank is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | Intranasal | 300 mcg per spray; 2-3 sprays daily | 8–12 weeks on / 4 weeks off |
| Conservative starter | Intranasal | 180 mcg per spray; 2-3 sprays daily | 4–6 weeks initial cycle |
| Men's Health focus | Intranasal | 300 mcg per spray; 2-3 sprays daily | Daily for 2-4 week courses |
| Maintenance phase | Intranasal | 210 mcg per spray; 2-3 sprays daily | Ongoing with periodic pauses |
Dose timing for Selank is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
Selank stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.
- Selank + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with Selank's mechanism in male physiology protocols.
- Selank + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with Selank's mechanism in male physiology protocols.
- Selank + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with Selank's mechanism in male physiology protocols.
- Selank + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Selank's mechanism in male physiology protocols.
Excellent. No reported dependence. Mild nasal irritation possible.
Lens-specific safety considerations for male physiology use of Selank: Excellent. No reported dependence. Mild nasal irritation possible. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| Selank | Tuftsin-derived heptapeptide anxiolytic | CNS effect lasts hours; plasma short | Men's Health |
| Kisspeptin | Hypothalamic upstream regulator of GnRH | ~28 min IV | The upstream master regulator of GnRH neurons — driving the entire HPG axis from above |
| Gonadorelin (GnRH) | Hypothalamic decapeptide | ~2-4 min | The natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy |
| PT-141 | Melanocortin receptor agonist | ~2-3 hr | An MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women |
How does Selank affect the HPG axis?
Will Selank affect fertility or sperm quality?
Best time of day to dose for male users?
Is Selank compatible with TRT?
Will Selank affect testosterone or my HPG axis?
Is Selank safe during pregnancy or breastfeeding?
Start a Selank Protocol
Alukard provides physician-supervised men's health protocols with GMP-certified Selank and GMP-certified compounds with comprehensive hormone panels.
Get ProtocolQuick Facts
- Molecular weight
- 751 Da
- Sequence length
- 7 aa
- Half-life
- CNS effect lasts hours; plasma short
- WADA
- Not on prohibited list
- FDA
- Unapproved (approved in Russia)
- Research
- Russian clinical trials in GAD
All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Selank unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Male Physiology Protocol for Selank
Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.
HIPAA Compliant · GMP Certified · Physician Supervised